Safety and Efficacy of Concurrent Immune Checkpoint Inhibitors and Hypofractionated Body Radiotherapy

OncoImmunology - United States
doi 10.1080/2162402x.2018.1440168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Survival Outcomes Following Combination Radiotherapy and Immune Checkpoint Inhibitors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

P1.16-29 Accelerated Hypofractionated Radiotherapy for Central Lung Tumors Unsuitable for Stereotactic Body Radiotherapy or Concurrent CRT

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy and Safety of Immune Checkpoint Therapy in Hepatocellular Carcinoma: Meta-Analysis

Hepatoma Research
2019English

Concurrent Therapy With Immune Checkpoint Inhibitors and TNFα Blockade in Patients With Gastrointestinal Immune-Related Adverse Events

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Receiving Concurrent Metformin and Immune Checkpoint Inhibitors

Lung Cancer Management
2019English

Review Article: Immune Checkpoint Inhibitors and the Liver, From Therapeutic Efficacy to Side Effects

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Safety and Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma With Portal Vein

HPB
HepatologyGastroenterology
2018English

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy